125 results
8-K
OCUP
Ocuphire Pharma Inc
16 Feb 24
Ocuphire Pharma Strengthens Leadership Team with Key Appointments
4:03pm
employment other than due to his death, disability or for cause, then he will be entitled to a lump sum payment equal to 0.75 times the sum of (a) his annual
8-K
EX-10.1
OCUP
Ocuphire Pharma Inc
16 Feb 24
Ocuphire Pharma Strengthens Leadership Team with Key Appointments
4:03pm
limitation, medical, prescription, dental, disability, employee life, group life, accidental death and travel accident insurance plans and programs … of Employment.
(a) Notwithstanding Section 1, the Employment Period shall end upon the earliest to occur of (i) the Executive’s death, (ii) a Termination
8-K
OCUP
Ocuphire Pharma Inc
5 Dec 23
Departure of Directors or Certain Officers
7:15pm
dates.
In the event of Mr. Patel’s death during the employment period or a termination due to disability, Mr. Patel, his beneficiaries or legal
8-K
EX-10.1
wbq5d
5 Dec 23
Departure of Directors or Certain Officers
7:15pm
8-K
08rs1c5
27 Nov 23
Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer
8:45am
8-K
EX-10.1
fypht204fv9mrms9zzth
27 Nov 23
Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer
8:45am
8-K
qhtu55
1 Nov 23
Ocuphire Pharma Announces Appointment of George Magrath, M.D., M.B.A., M.S., as Chief Executive Officer and Director
4:21pm
8-K
EX-10.1
cqn4nospf18tps6m0
1 Nov 23
Ocuphire Pharma Announces Appointment of George Magrath, M.D., M.B.A., M.S., as Chief Executive Officer and Director
4:21pm
8-K
EX-10.1
iuzqzcb
23 Jun 21
Entry into a Material Definitive Agreement
4:15pm